MEDICALSET: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICALSET
Largest movements
- Receivables within one year -€1,090
down €1,090 (-1.9%), from €56,044 to €54,954
- Cash -€880
down €880 (-29.2%), from €3,015 to €2,135
mainly Net result for the year (-€1,100) and Other debts (-€870)
- Profit (loss) carried forward -€1,100
down €1,100 (-4.9%), from €22,552 to €21,452
- Other debts -€870
down €870 (-15.2%), from €5,730 to €4,860
- Gross operating margin +€6,419
up €6,419 (+96.7%), from -€6,636 to -€217
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €59,258 | €57,288 | -€1,970 | -3.3% |
| Fixed assets | 21/28 | €199 | €199 | = | 0.0% |
| Financial fixed assets | 28 | €199 | €199 | = | 0.0% |
| Current assets | 29/58 | €59,059 | €57,089 | -€1,970 | -3.3% |
| Amounts receivable within one year | 40/41 | €56,044 | €54,954 | -€1,090 | -1.9% |
| Other amounts receivable | 41 | €56,044 | €54,954 | -€1,090 | -1.9% |
| Cash at bank and in hand | 54/58 | €3,015 | €2,135 | -€880 | -29.2% |
| Total equity and liabilities | 10/49 | €59,258 | €57,288 | -€1,970 | -3.3% |
| Equity | 10/15 | €53,528 | €52,428 | -€1,100 | -2.1% |
| Contributions | 10/11 | €20,823 | €20,823 | = | 0.0% |
| Reserves | 13 | €10,153 | €10,153 | = | 0.0% |
| Distributable reserves | 133 | €10,153 | €10,153 | = | 0.0% |
| Profit (loss) carried forward | 14 | €22,552 | €21,452 | -€1,100 | -4.9% |
| Amounts payable | 17/49 | €5,730 | €4,860 | -€870 | -15.2% |
| Amounts payable within one year | 42/48 | €5,730 | €4,860 | -€870 | -15.2% |
| Other amounts payable | 47/48 | €5,730 | €4,860 | -€870 | -15.2% |
| Other operating charges | 640/8 | €608 | €620 | +€12 | +2.0% |
| Gross operating margin | 9900 | -€6,636 | -€217 | +€6,419 | +96.7% |
| Operating profit (loss) | 9901 | -€7,244 | -€837 | +€6,407 | +88.4% |
| Financial charges | 65/66B | €276 | €263 | -€13 | -4.7% |
| Recurring financial charges | 65 | €276 | €263 | -€13 | -4.7% |
| Profit (loss) for the period before taxes | 9903 | -€7,520 | -€1,100 | +€6,420 | +85.4% |
| Profit (loss) for the period | 9904 | -€7,520 | -€1,100 | +€6,420 | +85.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,520 | -€1,100 | +€6,420 | +85.4% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.